San Francisco, CA, United States of America

Hans-Michael Jantzen

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999-2013

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Hans-Michael Jantzen

Introduction

Hans-Michael Jantzen is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as platelet ADP receptor inhibitors. With a total of 9 patents to his name, Jantzen's work has the potential to impact the treatment of cardiovascular diseases.

Latest Patents

Jantzen's latest patents focus on novel compounds of formulae (I) and (VIII). These compounds include sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives. These derivatives are effective platelet ADP receptor inhibitors and can be utilized in various pharmaceutical compositions. They are particularly effective for the prevention and treatment of cardiovascular diseases related to thrombosis. The invention also outlines a method for preventing or treating thrombosis in mammals by administering a therapeutically effective amount of these compounds or their pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Jantzen has worked with several prominent companies in the pharmaceutical industry. Notable among these are Portola Pharmaceuticals, Inc. and Cor Therapeutics, Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Jantzen has collaborated with several professionals in his field, including Pamela B Conley and Robert M Scarborough. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented inventions.

Conclusion

Hans-Michael Jantzen's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work on platelet ADP receptor inhibitors is particularly noteworthy, as it addresses critical health issues related to cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…